医学
比例危险模型
危险系数
队列
内科学
肾脏疾病
截肢
回顾性队列研究
置信区间
心脏病学
队列研究
外科
作者
Tetsuro Miyata,Hiraku Kumamaru,Shinsuke Mii,Naoko Kinukawa,Hiroaki Miyata,Kunihiro Shigematsu,Nobuyoshi Azuma,Atsuhisa Ishida,Yuichi Izumi,Yoshinori Inoue,Hisashi Uchida,Takao Ohki,Sosei Kuma,Koji Kurosawa,Akio Kodama,Hiroyoshi Komai,Kimihiro Komori,Takashi Shibuya,Shunya Shindo,Ikuo Sugimoto
标识
DOI:10.1016/j.ejvs.2022.05.038
摘要
The aim of this study was to create prediction models for two year overall survival (OS) and amputation free survival (AFS) after revascularisation in patients with chronic limb threatening ischaemia (CLTI).This was a retrospective analysis of prospectively collected multicentre registry data (JAPAN Critical Limb Ischaemia Database; JCLIMB). Data from 3 505 unique patients with CLTI who had undergone revascularisation from 2013 to 2017 were extracted from the JCLIMB for the analysis. The cohort was randomly divided into development (2 861 patients) and validation cohorts (644 patients). In the development cohort, multivariable risk models were constructed to predict two year OS and AFS using Cox proportional hazard regression analysis. These models were applied to the validation cohort and their performances were evaluated using Harrell's C index and calibration plots.Kaplan-Meier estimates of two year OS and AFS post-revascularisation in the whole cohort were 69% and 62%, respectively. Strong predictors for OS consisted of age, activity, malignant neoplasm, chronic kidney disease (CKD), congestive heart failure (CHF), geriatric nutritional risk index (GNRI), and sex. Strong predictors for AFS included age, activity, malignant neoplasm, CKD, CHF, GNRI, body temperature, white blood cells, urgent revascularisation procedure, and sex. Prediction models for two year OS and AFS showed good discrimination with Harrell's C indexes of 0.73 (95% confidence interval [CI] 0.69 - 0.77) and 0.72 (95% CI 0.68 - 0.76), respectively CONCLUSION: Prediction models for two year OS and AFS post-revascularisation in patients with CLTI were created. They can assist in determining treatment strategies and serve as risk adjustment modalities for quality benchmarking for revascularisation in patients with CLTI at each facility.
科研通智能强力驱动
Strongly Powered by AbleSci AI